JP2022503621A5 - - Google Patents
Info
- Publication number
- JP2022503621A5 JP2022503621A5 JP2021511584A JP2021511584A JP2022503621A5 JP 2022503621 A5 JP2022503621 A5 JP 2022503621A5 JP 2021511584 A JP2021511584 A JP 2021511584A JP 2021511584 A JP2021511584 A JP 2021511584A JP 2022503621 A5 JP2022503621 A5 JP 2022503621A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- domain
- binding
- pharmaceutical composition
- subject
- Prior art date
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862724597P | 2018-08-29 | 2018-08-29 | |
| US201862724600P | 2018-08-29 | 2018-08-29 | |
| US62/724,597 | 2018-08-29 | ||
| US62/724,600 | 2018-08-29 | ||
| US201862734951P | 2018-09-21 | 2018-09-21 | |
| US201862734950P | 2018-09-21 | 2018-09-21 | |
| US62/734,950 | 2018-09-21 | ||
| US62/734,951 | 2018-09-21 | ||
| US201962793235P | 2019-01-16 | 2019-01-16 | |
| US62/793,235 | 2019-01-16 | ||
| US201962832830P | 2019-04-11 | 2019-04-11 | |
| US62/832,830 | 2019-04-11 | ||
| US201962890217P | 2019-08-22 | 2019-08-22 | |
| US62/890,217 | 2019-08-22 | ||
| PCT/US2019/048916 WO2020047322A1 (en) | 2018-08-29 | 2019-08-29 | Combination therapies comprising tim-3-based chimeric proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022503621A JP2022503621A (ja) | 2022-01-12 |
| JP2022503621A5 true JP2022503621A5 (https=) | 2022-09-06 |
| JPWO2020047322A5 JPWO2020047322A5 (https=) | 2022-09-06 |
Family
ID=69643783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511584A Pending JP2022503621A (ja) | 2018-08-29 | 2019-08-29 | Ｔｉｍ－３系キメラタンパク質を含む併用療法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210179689A1 (https=) |
| EP (1) | EP3844185A4 (https=) |
| JP (1) | JP2022503621A (https=) |
| CN (1) | CN112888706A (https=) |
| AU (1) | AU2019328305A1 (https=) |
| CA (1) | CA3109349A1 (https=) |
| IL (1) | IL281123A (https=) |
| MX (1) | MX2021002291A (https=) |
| WO (1) | WO2020047322A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024123812A1 (en) | 2022-12-05 | 2024-06-13 | Shattuck Labs, Inc. | Fusion proteins for the treatment of cardiometabolic diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2017006320A (es) * | 2014-11-17 | 2017-08-10 | Genentech Inc | Terapia combinada que comprende agonistas de unión de ox40 y antagonistas de unión del eje de pd-1. |
| BR112017016681A2 (pt) * | 2015-02-06 | 2018-04-10 | Heat Biologics Inc | vetor de coexpressão de vacina e moléculas coestimulatórias |
| RU2766200C1 (ru) * | 2015-10-01 | 2022-02-09 | Хит Байолоджикс, Инк. | Композиции и способы для соединения внеклеточных доменов типа i и типа ii в качестве гетерологичных химерных белков |
| US20170145103A1 (en) * | 2015-11-23 | 2017-05-25 | Five Prime Therapeutics, Inc. | Predicting response to cancer treatment with fgfr2 inhibitors |
| MX2019009812A (es) * | 2017-02-27 | 2019-10-14 | Shattuck Labs Inc | Proteinas quimericas basadas en tigit y light. |
-
2019
- 2019-08-29 AU AU2019328305A patent/AU2019328305A1/en not_active Abandoned
- 2019-08-29 MX MX2021002291A patent/MX2021002291A/es unknown
- 2019-08-29 WO PCT/US2019/048916 patent/WO2020047322A1/en not_active Ceased
- 2019-08-29 EP EP19856345.4A patent/EP3844185A4/en not_active Withdrawn
- 2019-08-29 JP JP2021511584A patent/JP2022503621A/ja active Pending
- 2019-08-29 US US17/265,684 patent/US20210179689A1/en not_active Abandoned
- 2019-08-29 CA CA3109349A patent/CA3109349A1/en active Pending
- 2019-08-29 CN CN201980070366.7A patent/CN112888706A/zh active Pending
-
2021
- 2021-02-25 IL IL281123A patent/IL281123A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10766943B2 (en) | Universal chimeric antigen expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders | |
| JP2022512541A5 (https=) | ||
| US20200087377A1 (en) | Multifunctional Fusion Protein and Applications Thereof | |
| JP2020530298A5 (https=) | ||
| JP2020508068A5 (https=) | ||
| JP7464525B2 (ja) | 標的療法のためのチェックポイント遮断を組み合わせる二官能性タンパク質 | |
| IL279146B1 (en) | Reverse chimeric universal antigen receptor (RevCAR) expressing immune cells targeting multiple and different antigens, method of making them and use thereof for treating cancer, infections and autoimmune disorders | |
| JP2022511286A5 (https=) | ||
| JP2020506727A5 (https=) | ||
| TW201718646A (zh) | Ｔｉｇｉｔ結合劑和彼之用途 | |
| JP2021512151A5 (https=) | ||
| JP7578869B2 (ja) | Ｃｄ３００ｃ抗原またはその受容体に特異的に結合するキメラ抗原受容体 | |
| TW202116811A (zh) | 調節免疫檢查點作為癌症治療的單特異性蛋白質、其醫藥組成物、其核酸、及其用途 | |
| JP2025118769A5 (https=) | ||
| JP7033601B2 (ja) | 抗コチニンキメラ抗原受容体を発現するナチュラルキラー細胞 | |
| JP2022512539A5 (https=) | ||
| CN114616251B (zh) | 靶向PD-1和TGFβ的重组蛋白 | |
| JP2022503621A5 (https=) | ||
| US11866493B2 (en) | Single-chain variable fragment of Met monoclonal antibody and methods of use in CAR T cell therapy | |
| JPWO2020047328A5 (https=) | ||
| JPWO2020047319A5 (https=) | ||
| EP4545631A1 (en) | Immune cell expressing immune checkpoint regulator, and use thereof | |
| JP2012025694A (ja) | 癌治療剤 | |
| JPWO2020047325A5 (https=) | ||
| CA3195627A1 (en) | Il-2/il-15r.beta..gamma. agonist for treating squamous cell carcinoma |